Related Experiment Video
Updated: Jun 16, 2026
09:39
Assessing Specificity of Anticancer Drugs In Vitro
Published on: March 23, 2016
Exploring Punicalagin Potential Against Cancers: A Comprehensive Review
Muhammad Hammad Ul Hassan1, Muhammad Shahbaz1, Ushna Momal1
1Department of Food Science and Technology Muhammad Nawaz Shareef University of Agriculture Multan Multan Pakistan.
Food Science & Nutrition
|February 28, 2025
Summary
Punicalagin, a polyphenol, shows promise in fighting various cancers by inhibiting tumor growth and cell proliferation. Further clinical trials are needed to confirm its therapeutic potential and safety as an alternative cancer treatment.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Punicalagin is a bioactive polyphenol with demonstrated anticancer properties.
- It has garnered interest for its potential to inhibit cancer cell proliferation and tumor growth.
Purpose of the Study:
- To highlight the therapeutic potential of punicalagin against various tumors and cancers.
- To explore the cellular mechanisms by which punicalagin exerts its anticancer effects.
Main Methods:
- Review of existing research on punicalagin's effects in various cancer models.
- Analysis of punicalagin's impact on key signaling pathways (MAPK/ERK, PI3K/AKT/mTOR).
- Investigation of punicalagin's inhibition of factors like VEGF, MMP-9, uPA, and AR.
Main Results:
- Punicalagin demonstrated tumor cell elimination in liver, stomach, prostate, and lung cancer models.
- It inhibits critical cancer-promoting pathways and proteins, including MAPK/ERK, PI3K/AKT/mTOR, and the androgen receptor.
- Punicalagin reduces metastasis and induces apoptosis in colon cancer cells by inhibiting cyclins.
Conclusions:
- Punicalagin exhibits significant potential as an anticancer agent through multiple mechanisms.
- It inhibits tumor growth, proliferation, metastasis, and angiogenesis.
- Further clinical studies are essential to establish punicalagin's efficacy and safety for cancer treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...